We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,680 hedge funds and large institutions have $260B invested in Johnson & Johnson in 2023 Q3 according to their latest regulatory filings, with 151 funds opening new positions, 1,220 increasing their positions, 2,000 reducing their positions, and 181 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more call options, than puts

Call options by funds: $3.26B | Put options by funds: $2.81B

0.63% less ownership

Funds ownership: 69.83%69.2% (-0.63%)

2% less funds holding

Funds holding: 3,7533,680 (-73)

13% less capital invested

Capital invested by funds: $300B → $260B (-$40B)

17% less first-time investments, than exits

New positions opened: 151 | Existing positions closed: 181

19% less funds holding in top 10

Funds holding in top 10: 457370 (-87)

39% less repeat investments, than reductions

Existing positions increased: 1,220 | Existing positions reduced: 2,000

Holders
3,680
Holders Change
-73
Holders Change %
-1.95%
% of All Funds
58.38%
Holding in Top 10
370
Holding in Top 10 Change
-87
Holding in Top 10 Change %
-19.04%
% of All Funds
5.87%
New
151
Increased
1,220
Reduced
2,000
Closed
181
Calls
$3.26B
Puts
$2.81B
Net Calls
+$450M
Net Calls Change
-$1.15B
Name Holding Trade Value Shares
Change
Change in
Stake
BIA
1001
Biondo Investment Advisors
Pennsylvania
$8.29M +$309K +1,875 +4%
PWP
1002
Perfromance Wealth Partners
Illinois
$8.27M +$109K +660 +1%
BIM
1003
Bridges Investment Management
Nebraska
$8.26M -$1.07M -6,506 -11%
WA
1004
Waverly Advisors
Alabama
$8.26M +$5.29M +32,084 +153%
FFA
1005
First Foundation Advisors
California
$8.26M +$266K +1,613 +3%
JC
1006
Jacobs & Co
California
$8.24M -$1.49M -9,059 -15%
MPM
1007
Meritage Portfolio Management
Kansas
$8.21M -$245K -1,483 -3%
SAM
1008
Sompo Asset Management
Japan
$8.19M -$2.64M -16,020 -23%
KIG
1009
Kessler Investment Group
Indiana
$8.17M +$161K +974 +2%
OCM
1010
One Capital Management
California
$8.16M +$213K +1,289 +3%
PCA
1011
Pallas Capital Advisors
Massachusetts
$8.16M -$2.45M -14,840 -21%
SGC
1012
Slocum, Gordon & Co
Rhode Island
$8.15M -$1.2M -7,249 -12%
SCP
1013
Stamos Capital Partners
California
$8.14M +$66K +400 +0.8%
EWM
1014
Executive Wealth Management
Michigan
$8.12M +$144K +874 +2%
HAIM
1015
Hunter Associates Investment Management
Pennsylvania
$8.1M -$723K -4,381 -8%
NME
1016
Notis-McConarty Edward
$8.08M -$660 -4 -0%
MFS
1017
Mirabella Financial Services
United Kingdom
$8.07M -$116K -705 -1%
DAS
1018
Dynamic Advisor Solutions
Arizona
$8.06M +$83.3K +505 +1%
WAM
1019
Wolverine Asset Management
Illinois
$8.04M +$8.52M +51,642 New
FDP
1020
Financiere des Professionnels
Quebec, Canada
$8.03M +$8.51M +51,587 New
BCM
1021
Bayesian Capital Management
New York
$7.99M +$5.56M +33,680 +191%
FFM
1022
Fullerton Fund Management
Singapore
$7.97M -$1.57M -9,502 -16%
Verition Fund Management
1023
Verition Fund Management
Connecticut
$7.93M -$1.88M -11,405 -18%
GIA
1024
GHP Investment Advisors
Colorado
$7.93M +$222K +1,345 +3%
WB
1025
Webster Bank
Connecticut
$7.91M -$45.5K -276 -0.5%

JNJ Hedge Fund Activity: Q3 2023 in Review

3,680 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2023, worth a combined $260B — down 13% from $300B a quarter earlier.

Sellers outnumbered buyers: 181 funds closed out of JNJ and 151 opened new positions — a net loss of 30 holders — while 2,000 trimmed existing stakes and 1,220 added.

The largest buyer was Goldman Sachs, adding an estimated $394M. The largest seller was Vanguard Group, cutting an estimated $3B.

  • 3,680 institutional investors held Johnson & Johnson (JNJ) as of Q3 2023, down from 3,753 in Q2 2023.
  • Funds reported $260B of Johnson & Johnson stock for Q3 2023, down 13% quarter-over-quarter.
  • 151 funds opened new Johnson & Johnson positions in Q3 2023 and 181 closed out, a net change of -30 holders.
  • The largest Johnson & Johnson buyer in Q3 2023 was Goldman Sachs, an estimated $394M added.
  • The largest Johnson & Johnson seller in Q3 2023 was Vanguard Group, an estimated $3B sold.

Based on aggregated 13F filings for Q3 2023.